TSS
GOSS icon

Two Sigma Securities’s Gossamer Bio GOSS Stock Holding History

Two Sigma Securities’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,056
Closed -$83.9K – 1846
2025
Q4 		$83.9K Buy
27,056
+10,719
+66% +$30.6K 0.01% 1002
2025
Q3 		$43K Buy
+16,337
New +$36K 0.01% 1009
2024
Q1 		– Sell
-31,683
Closed -$28.9K – 3200
2023
Q4 		$28.9K Buy
31,683
+21,359
+207% +$15.8K ﹤0.01% 2670
2023
Q3 		$8.6K Buy
+10,324
New +$11.9K ﹤0.01% 2721
2023
Q1 		– Sell
-109,084
Closed -$237K – 2895
2022
Q4 		$237K Buy
+109,084
New +$898K 0.01% 1773

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Two Sigma Securities's GOSS Position: Q1 2026 in Review

Two Sigma Securities sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 27,056 shares — an estimated $83.9K sold.

Two Sigma Securities first reported a position in GOSS in Q4 2022 and held it in 5 quarters. The position peaked at $237K in Q4 2022. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Two Sigma Securities reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 27,056 Gossamer Bio shares in Q1 2026, an estimated $83.9K.
  • Two Sigma Securities first reported a position in Gossamer Bio in Q4 2022 and held it in 5 quarters.
  • Two Sigma Securities's Gossamer Bio position peaked at $237K in Q4 2022.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.